CD44 (CD44v6) |
Glycosylated transmembrane receptor |
Tumor initiation, transcoelomic metastasis, hematogenous metastasis, chemoresistance |
[27,30,33,37,38,39,40] |
CD117 |
Tyrosine kinase receptor |
Tumor initiation, transcoelomic metastasis, chemoresistance |
[33,41,42] |
ALDH |
Enzyme responsible for oxidizing intracellular aldehydes |
Tumor initiation, transcoelomic metastasis, hematogenous metastasis, chemoresistance |
[29,31,34,40,41,43,44,45] |
CD133 |
Pentaspan transmembrane glycoprotein |
Tumor initiation, adhesion, invasion, transcoelomic metastasis, chemoresistance |
[28,29,32,34,40,46] |
CD24 |
Mucin-like cell surface glycoprotein |
Tumor initiation, self-renewal, multi-differentiation, transcoelomic metastasis, chemoresistance |
[27,35,45,47] |
EpCAM |
Type I transmembrane glycoprotein |
Tumor initiation, multi-differentiation, sphere formation, chemoresistance, prevention of chemotherapy induced-apoptosis |
[27,36,45,48] |
Wnt |
Palmitoylated secreted glycoprotein |
chemoresistance |
[42,45,49] |
Nothch |
Type I transmembrane glycoprotein |
chemoresistance |
[50,51] |
Hedgehog |
Secreted signaling protein |
chemoresistance |
[52,53,54] |